1 – 144 of 144
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
SERPINH1 variants and thrombotic risk among middle-aged and older adults : a population-based cohort study
(
- Contribution to journal › Letter
-
Mark
The risk for venous thromboembolism and cardiometabolic disorders in offspring from thrombosis-prone pedigrees
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
-
Mark
Thromboembolic and bleeding risk in cardiac amyloidosis
(
- Contribution to journal › Scientific review
-
Mark
Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia : data from the PedNet cohort
2024) In Journal of Thrombosis and Haemostasis(
- Contribution to journal › Article
- 2023
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
-
Mark
"Hereditary angioedema is associated with an increased risk of venous thromboembolism" : reply
(
- Contribution to journal › Letter
-
Mark
Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders
(
- Contribution to journal › Article
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
(
- Contribution to journal › Article
-
Mark
“C1-inhibitor levels and Venous Thromboembolism : Results from a Mendelian Randomization Study”: comment from Grover et al
(
- Contribution to journal › Letter
- 2022
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study
(
- Contribution to journal › Article
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
(
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
Hereditary angioedema is associated with an increased risk of venous thromboembolism
(
- Contribution to journal › Letter
- 2021
-
Mark
Pleiotropic anticoagulant functions of protein S, consequences for the clinical laboratory. Communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
Megakaryocytes listen for their progeny’s progeny during inflammation
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Droplet digital PCR and mile-post analysis for the detection of F8 int1h inversions
(
- Contribution to journal › Article
-
Mark
Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme
(
- Contribution to journal › Letter
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer
(
- Contribution to journal › Article
-
Mark
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine : COMMENT from Gruel et al.: RESPONSE from Kahn et al.
(
- Contribution to journal › Letter
-
Mark
The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark
(
- Contribution to journal › Article
- 2020
-
Mark
Detection of F8 int22h inversions using digital droplet PCR and mile-post assays
(
- Contribution to journal › Article
-
Mark
Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis : A diagnostic individual patient data meta-analysis
(
- Contribution to journal › Article
-
Mark
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays
(
- Contribution to journal › Article
-
Mark
Diagnosing deep vein thrombosis in cancer patients with suspected symptoms : An individual participant data meta-analysis
(
- Contribution to journal › Article
-
Mark
Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease : Results from 3WINTERS-IPS, an international and collaborative cross-sectional study
(
- Contribution to journal › Article
- 2019
-
Mark
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short
(
- Contribution to journal › Article
- 2018
-
Mark
Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity
(
- Contribution to journal › Article
- 2017
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients : Results of the INSIGHT case-control study
(
- Contribution to journal › Article
-
Mark
Effect of late prophylaxis in hemophilia on joint status : A randomized trial
(
- Contribution to journal › Article
-
Mark
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S
(
- Contribution to journal › Article
- 2016
-
Mark
Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.
(
- Contribution to journal › Article
-
Mark
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
(
- Contribution to journal › Article
-
Mark
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
(
- Contribution to journal › Article
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
(
- Contribution to journal › Article
- 2015
-
Mark
Role of family history of venous thromboembolism (VTE) and thrombophilia as predictors of VTE recurrence: a prospective follow-up study.
(
- Contribution to journal › Article
-
Mark
Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.
(
- Contribution to journal › Article
-
Mark
Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.
(
- Contribution to journal › Article
- 2014
-
Mark
Definitions in hemophilia: communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
Family history of venous thromboembolism (VTE) and risk of recurrent hospitalization for VTE: a nationwide family study in Sweden.
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
(
- Contribution to journal › Article
-
Mark
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma
(
- Contribution to journal › Article
- 2013
-
Mark
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
-
Mark
40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa : A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
(
- Contribution to journal › Article
- 2012
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
(
- Contribution to journal › Article
-
Mark
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
(
- Contribution to journal › Letter
-
Mark
Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.
(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia A mutations
(
- Contribution to journal › Article
-
Mark
Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.
(
- Contribution to journal › Letter
-
Mark
Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.
(
- Contribution to journal › Article
-
Mark
Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.
(
- Contribution to journal › Letter
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
- 2011
-
Mark
Parental history and venous thromboembolism: a nationwide study of age and sex-specific familial risks in Sweden.
(
- Contribution to journal › Article
-
Mark
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.
(
- Contribution to journal › Article
-
Mark
Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.
(
- Contribution to journal › Article
-
Mark
Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.
(
- Contribution to journal › Article
-
Mark
A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).
(
- Contribution to journal › Article
-
Mark
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
(
- Contribution to journal › Article
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462(
- Contribution to journal › Published meeting abstract
-
Mark
Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test
2011) International congress thrombosis hemostasis In Journal of Thrombosis and Haemostasis 9(s2). p.91-91(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.
(
- Contribution to journal › Article
-
Mark
Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.
(
- Contribution to journal › Article
-
Mark
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
(
- Contribution to journal › Article
-
Mark
rFVIIa transported from the blood stream into tissues is functionally active
(
- Contribution to journal › Letter
-
Mark
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B
(
- Contribution to journal › Published meeting abstract
-
Mark
APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.
(
- Contribution to journal › Article
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
- 2009
-
Mark
Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis
(
- Contribution to journal › Article
-
Mark
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
(
- Contribution to journal › Article
-
Mark
The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?
(
- Contribution to journal › Article
-
Mark
Can proteins induced by vitamin K absence - PIVKA-II - detect subclinical vitamin k deficit in major surgery?
2009) International Congress on Thrombosis and Hemostasis, 2009 In Journal of Thrombosis and Haemostasis 7(s2). p.404-404(
- Contribution to journal › Published meeting abstract
-
Mark
An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and aPTT
2009) International Congress on Thrombosis and Hemostasis, 2009 In Journal of Thrombosis and Haemostasis 7(s2). p.871-872(
- Contribution to journal › Published meeting abstract
-
Mark
Autologous plasma for the study of anaphylatoxinkinetics in man
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2).(
- Contribution to journal › Published meeting abstract
-
Mark
Prothrombin complex concentrate and effects on thecone and plate analyser
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.885-885(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of two different heparin doses inperipheral vascular surgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2).(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of two infusionrates of antithrombinconcentrate in cardiopulmonary bypass surgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1075-1075(
- Contribution to journal › Published meeting abstract
-
Mark
Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery
2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1167-1167(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
(
- Contribution to journal › Article
-
Mark
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
(
- Contribution to journal › Article
- 2007
-
Mark
High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsies
(
- Contribution to journal › Letter
-
Mark
Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
(
- Contribution to journal › Article
-
Mark
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients
(
- Contribution to journal › Article
-
Mark
An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
(
- Contribution to journal › Article
-
Mark
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
(
- Contribution to journal › Article
- 2006
-
Mark
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
(
- Contribution to journal › Scientific review
-
Mark
Are randomized clinical trials the only truth? Not always
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
(
- Contribution to journal › Article
-
Mark
The von Willebrand disease prophylaxis network: exploring a treatment concept.
(
- Contribution to journal › Article
-
Mark
The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
(
- Contribution to journal › Article
-
Mark
Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes
(
- Contribution to journal › Letter
-
Mark
From gamma-carboxy-glutamate to protein C.
(
- Contribution to journal › Article
-
Mark
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance - in the absence of factor V Leiden - and pregnancy.
(
- Contribution to journal › Article
-
Mark
Family secrets to be disclosed.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study
(
- Contribution to journal › Article
-
Mark
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis
(
- Contribution to journal › Article
-
Mark
Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects
(
- Contribution to journal › Letter
-
Mark
Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies
(
- Contribution to journal › Article
-
Mark
The natural course of women with recurrent fetal loss
(
- Contribution to journal › Article
- 2005
-
Mark
Post-translational modifications in proteins involved in blood coagulation.
(
- Contribution to journal › Scientific review
-
Mark
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study
(
- Contribution to journal › Article
-
Mark
The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia
(
- Contribution to journal › Article
-
Mark
Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
(
- Contribution to journal › Article
-
Mark
Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.
(
- Contribution to journal › Article
-
Mark
APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
(
- Contribution to journal › Letter
-
Mark
Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?
(
- Contribution to journal › Letter
-
Mark
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal
(
- Contribution to journal › Letter
-
Mark
Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.
(
- Contribution to journal › Article
-
Mark
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
(
- Contribution to journal › Article
-
Mark
Factor H binds to washed human platelets
(
- Contribution to journal › Article
- 2004
-
Mark
Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Hereditary thrombophilia and fetal loss: a prospective follow-up study
(
- Contribution to journal › Article
-
Mark
The multiple faces of the partial thromboplastin time APTT.
(
- Contribution to journal › Letter
-
Mark
Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.
(
- Contribution to journal › Article
-
Mark
Familial thrombophilia and lifetime risk of venous thrombosis
(
- Contribution to journal › Article
- 2003
-
Mark
Monitoring the bioavailability of FEIBA with a thrombin generation assay
(
- Contribution to journal › Article
-
Mark
The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX
(
- Contribution to journal › Article
-
Mark
Quantification of ADP and ATP receptor expression in human platelets.
(
- Contribution to journal › Article
-
Mark
Superantigens from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1beta.
(
- Contribution to journal › Article
-
Mark
Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system
(
- Contribution to journal › Letter
-
Mark
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
(
- Contribution to journal › Article
-
Mark
Molecular recognition in the protein C anticoagulant pathway.
(
- Contribution to journal › Article
-
Mark
Thrombosis in inherited factor VII deficiency.
(
- Contribution to journal › Article
-
Mark
Desmopressin (DDAVP) and factor VIII
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.
(
- Contribution to journal › Article
-
Mark
The discovery of activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.
(
- Contribution to journal › Letter
-
Mark
Fresh frozen plasma reduces thrombin formation in newborn infants
(
- Contribution to journal › Article
-
Mark
Superantigens from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1 beta
(
- Contribution to journal › Article
-
Mark
Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma.
(
- Contribution to journal › Article